Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VibeX and KXL System for Corneal Ectasia after Refractive Surgery
NCT01643252Phase 3Withdrawn
- Sponsor
- Glaukos Corporation
- Start
- Jul 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of riboflavin in corneal ectasia, sponsored by Glaukos Corporation. Planned start Jul 2012; status: withdrawn.
02
Drugs
riboflavin
03
Conditions
corneal ectasia
Beyond the preview
Go deeper on NCT01643252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643252.